BHR Partners, a private equity firm co-founded by Hunter Biden alongside Chinese Communist Party-run financial institutions, is funding Insilico Medicine, a biotechnology company working on COVID-19 treatments that recently partnered with Pfizer.
- Biden's son pledged to divest his 10% stake in Biden's investment fund, but Biden still owns 10%
- War Room can reveal that BHR is funding the biotechnology firm, which is actively engaged in - and ostensibly profiting from - a search for COVID -19 drugs and treatments
- In May, the company announced that it had discovered a preclinical candidate for the treatment of the coronavirus
No comments:
Post a Comment